fusidic acid has been researched along with rifampin in 150 studies
| Studies (fusidic acid) | Trials (fusidic acid) | Recent Studies (post-2010) (fusidic acid) | Studies (rifampin) | Trials (rifampin) | Recent Studies (post-2010) (rifampin) |
|---|---|---|---|---|---|
| 1,742 | 117 | 344 | 20,468 | 1,499 | 6,552 |
| Protein | Taxonomy | fusidic acid (IC50) | rifampin (IC50) |
|---|---|---|---|
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.949 | |
| Caspase-1 | Homo sapiens (human) | 8.319 | |
| Alpha-synuclein | Homo sapiens (human) | 7.1 | |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | Mycobacterium tuberculosis H37Rv | 0.03 | |
| DNA-directed RNA polymerase subunit beta | Mycobacterium tuberculosis H37Rv | 0.01 | |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 1.5 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 1.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 48 (32.00) | 18.7374 |
| 1990's | 21 (14.00) | 18.2507 |
| 2000's | 31 (20.67) | 29.6817 |
| 2010's | 42 (28.00) | 24.3611 |
| 2020's | 8 (5.33) | 2.80 |
| Authors | Studies |
|---|---|
| Andersson, DI; Maisnier-Patin, S; Paulander, W; Pennhag, A | 1 |
| Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
| Beceiro, A; Bou, G; Canle, D; Fernández, A; Lasa, I; Latasa, C; Mallo, S; Molina, F; Pérez, A; Pérez, S; Poza, M; Tomás, Mdel M; Villanueva, R | 1 |
| Amblard, M; Bastide, L; Gualtieri, M; Leonetti, JP; Martinez, J; Pugniere, M; Roquet, F; Villain-Guillot, P | 1 |
| Bryce, E; Gravel, D; Loeb, M; Louie, L; Matlow, A; McGeer, A; Mulvey, M; Ofner-Agostini, M; Simor, AE; Stuart, TL; Watt, C | 1 |
| Arpin, C; Fournier, M; Gagné, S; Hernould, M; Quentin, C | 1 |
| Chopra, I; Ingham, E; Miller, K; O'Neill, AJ; Wilcox, MH | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Apajalahti, J; Fox, J; Frimodt-Møller, N; Hansen, F; Loidl, G; Nagai, J; Siikanen, O; Takano, M; Vaara, M; Vaara, T | 1 |
| Banères-Roquet, F; Gualtieri, M; Leonetti, JP; Pugnière, M; Villain-Guillot, P | 1 |
| Denis, O; Nguyen, HA; Struelens, MJ; Theunis, A; Tulkens, PM; Van Bambeke, F; Vergison, A | 1 |
| Desplaces, N; Dzeing-Ella, A; Kitzis, MD; Mamoudy, P; Zeller, V; Ziza, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bavari, S; Bowlin, TL; Houseweart, C; Moir, DT; Opperman, TJ; Panchal, RG; Peet, NP; Williams, JD | 1 |
| Apajalahti, J; Fox, J; Frimodt-Møller, N; He, H; Li, J; Nation, RL; Poudyal, A; Siikanen, O; Vaara, M; Vaara, T | 1 |
| Bohnert, JA; Karamian, B; Nikaido, H | 1 |
| Basset, P; Blanc, DS; Senn, L; Vogel, V; Zanetti, G | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Duerink, DO; Fluit, AC; Goessens, WH; Hadi, U; Horst-Kreft, D; Kuntaman, K; Lemmens-den Toom, N; Lestari, ES; Pastink, M; Severin, JA; Snijders, SV; van Belkum, A; van Wamel, W; Verbrugh, HA | 1 |
| Floyd, JL; Floyd, JT; Kumar, SH; Smith, KP; Varela, MF | 1 |
| Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Athanassopoulos, CM; Dinos, GP; Garnelis, T; Kalpaxis, DL; Kostopoulou, ON; Kournoutou, GG; Leotsinidis, M; Magoulas, GE; Papaioannou, D | 1 |
| Brozovic, A; Dowson, CG; Gazvoda, M; Košmrlj, J; Lloyd, A; Osmak, M; Proud, C; Roper, DI; Vajs, J | 1 |
| Ashenden, S; Bender, A; Cokol, M; Karakoc, I; Kuru, N; Mason, DJ; Meral, S; Stott, I; Weinstein, ZB | 1 |
| Chibale, K; Dziwornu, GA; Kaur, G; Okombo, J; Shanika, PS; Singh, K | 1 |
| Abuelkhir, AA; Abutaleb, NS; Attia, AS; Elsebaie, MM; Liang, HW; Mayhoub, AS; Nour El-Din, HT; Seleem, MN | 1 |
| Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF | 1 |
| Akhir, A; Chopra, S; Kaul, G; Meenu, MT; Radhakrishnan, KV; Shukla, M | 1 |
| Ashmarin, IP; Avenirova, EL; Lapina, IK; Movchan, NA | 1 |
| Lowery, C; Richardson, JP | 1 |
| Cohen, PS; Ennis, HL; Pennica, D; Walker, AC; Walsh, ML | 1 |
| Bernheimer, H; Fox, MS; Tiraby, G | 1 |
| Carlström, A; Dornbusch, K; Hagelberg, A | 1 |
| Forsgren, A; Schmeling, D | 1 |
| Hossack, G; Paddock, G; Parsons, RL | 1 |
| Briedigkeit, H; Halle, E | 1 |
| Vaara, M | 2 |
| Brockmeyer, NH; Goos, M; Mertins, L | 1 |
| Simon, M; Simon, VC | 1 |
| Blakemore, PH; Drabu, YJ | 1 |
| Jaakkola, J; Vaara, M | 1 |
| Kim, KS; Lakshmi, TM | 1 |
| Gutschik, E; Røder, BL | 1 |
| Pohlod, DJ; Saravolatz, LD; Somerville, MM | 1 |
| Lynch, WH; McCashion, RN | 1 |
| Gray, GD; Ohlmann, GM | 2 |
| Durgham, SM; Ishag, AH; Shibl, AM | 1 |
| Brumfitt, W; Dixson, S; Hamilton-Miller, JM | 1 |
| Falkiner, FR; Jones, L; Keane, CT; Mooney, D; Moorhouse, EC; Mulvihill, TE | 1 |
| Khamidov, ShA; Kilichev, RM; Valikhanov, UA | 1 |
| Cohen, J; Ferreira, AC | 1 |
| Durgham, SM; Ishag, AJ; Shibl, AM | 1 |
| de Saxe, MJ; Marples, RR; Richardson, JF | 1 |
| Farber, BF; Karchmer, AW; Yee, YC | 1 |
| Bourgault, AM; Bryan, L; Harding, GJ; Henry, DA; Hoban, DJ; Horsman, GB; Marrie, T; Smith, JA; Turgeon, P | 1 |
| Ravin, AW; Tiraby, G | 1 |
| Davies, J; Weisblum, B | 1 |
| Apirion, D; Gurgo, C; Luzzatto, L; Schlessinger, D | 1 |
| Beck, D; Siegenthaler, G; Siegenthaler, W; Weidmann, P | 1 |
| Gombosuren, T; Jezek, Z; Mingir, G; Rusinko, M | 1 |
| Fomina, IP; Kuznetsova, SM; Speranskaia, ON | 1 |
| Jeljaszewicz, J; Pulverer, G | 1 |
| Josse, RG | 1 |
| George, RH | 1 |
| Kjeldgaard, NO; Lund, E | 1 |
| Bennett, PM; Hansen, MT; von Meyenburg, K | 1 |
| Both, GW; Elliott, WH; Glenn, AR; May, BK; McInnes, JL | 1 |
| Kobayashi, GS; Kwan, CN; Medoff, G; Schlessinger, D | 1 |
| Eykyn, SJ; Phillips, I | 1 |
| Koelman, A; Mouton, RP | 1 |
| Both, GW; Elliott, WH; Hanlon, JE; May, BK; McInnes, JL | 1 |
| Jensen, K | 1 |
| Shanson, DC | 1 |
| Klastersky, J; Lagast, H; Zinner, SH | 1 |
| Emmerson, AM; Grüneberg, RN; Ridgway, GL | 1 |
| Archer, G; Bornholm, J; Yu, VL; Zuravleff, JJ | 1 |
| Emmerson, AM; Grüneberg, RN | 1 |
| Foldes, M; Munro, R; Shanker, S; Sorrell, TC; Toohey, M | 1 |
| Harvey, K; Pavillard, R | 1 |
| Høiby, N; Szaff, M | 1 |
| Caillon, J; Drugeon, HB; Juvin, ME | 1 |
| Chaouat, A; Grunenberger, S; Ifoundza, TP; Kessler, R; Weitzenblum, E | 1 |
| Porro, M; Vaara, M | 1 |
| Gaya, H; Wilson, AP | 1 |
| Argenson, JN; Drancourt, M; Groulier, P; Raoult, D; Roiron, R; Stein, A | 1 |
| Bryskier, A; Capper, T; Klugman, KP | 1 |
| Pulverer, G; Schierholz, JM | 2 |
| Dan, M; Priel, I; Turkisher, V | 1 |
| Fallgren, C; Ljungh, A; Petersson, AC; Utt, M; Wadström, T | 1 |
| Hay, RJ; Nasher, MA | 1 |
| Gottlieb, T; Mitchell, D | 1 |
| Ansorg, R; Fabry, W; Schmid, EN | 1 |
| Beuth, J; Pulverer, G; Schierholz, JM | 1 |
| Black, FT; Nielsen, SL | 1 |
| Chopra, I; Cove, JH; O'Neill, AJ | 1 |
| Millar, C; Page, T; Paterson, P; Taylor, CP | 1 |
| Kamel, AGM; Koh, YT; Lim, VKE; Ng, PP; Norazah, A; Rohani, MY; Spencer, K; Zuridah, H | 1 |
| Grohs, P; Gutmann, L; Kitzis, MD | 1 |
| Dudzevicius, V; Sakalauskas, R; Vitkauskiene, A | 1 |
| Bell, SC; Bunting, JP; Coulter, C; Franks, CA; Gan, R; Garske, LA; Kidd, TJ; Masel, PJ | 1 |
| Hårdemark, HG; Hedberg, A; Olsson-Liljequist, B; Sjölin, J | 1 |
| Hughes, D; Macvanin, M | 1 |
| Bell, SC; Coulter, C; Downey, DG; Kidd, TJ | 1 |
| Aaron, SD; Chan, F; Ferris, W; Lee, C; Ramotar, K; Saginur, R; Stdenis, M | 1 |
| Caldwell, F; Kreiswirth, BN; Low, DE; McGeer, A; Rousseau, J; Weese, JS; Willey, BM | 1 |
| Chan, RC; Donaldson, AD; Gosbell, IB | 1 |
| Kamel, AG; Lim, VK; Norazah, A; Rohani, MY | 1 |
| Apisarnthanarak, A; Mundy, LM | 1 |
| Korres, D; Mastrokalos, DS; Soucacos, PN; Zahos, KA | 1 |
| Fair, R; Leavy, A; Macfarlane, M; McCaughan, J; Reid, AJ | 1 |
| Aboltins, CA; Buising, KL; Choong, PF; Daffy, JR; Jenney, AW; Page, MA; Stanley, PA | 1 |
| Badiou, C; Bes, M; Dumitrescu, O; Etienne, J; Lina, G; Reverdy, ME; Vandenesch, F | 1 |
| Arias, CA; Bourgogne, A; Buhay, C; Chen, G; Chen, L; Chowdhury, S; Ding, Y; Dugan-Rocha, S; Fox, KA; Garsin, DA; Gibbs, RA; Gioia, J; Highlander, SK; Jiang, H; Maadani, A; Murray, BE; Muzny, D; Nallapareddy, SR; Prakash, VP; Qin, X; Shang, Y; Shen, H; Sillanpaa, J; Singh, KV; Weinstock, GM; Williams, G; Yerrapragada, S; Zhao, M | 1 |
| Ahamed Puthiyaveetil, S | 1 |
| Backhaus, T; Brosche, S | 1 |
| Bogomolova, NS; Bol'shakov, LV; Kuznetsova, SM; Oreshkina, TD | 1 |
| Burt, HM; Gilchrist, SE; Letchford, K; Needham, D; Rickard, DL | 1 |
| Aboltins, CA; Buising, KL; Choong, PF; Daffy, JR; Dowsey, MM; Peel, TN; Stanley, PA | 1 |
| Bach, H; Burt, HM; Fazli, L; Gilchrist, SE; Lange, D; Letchford, K | 1 |
| Lim, KT; Teh, CS; Thong, KL; Yusof, MY | 1 |
| De Wachter, E; Malfroot, A; Schuermans, D; Vanderhelst, E; Verbanck, S; Vincken, W; Willekens, J | 1 |
| Alshafi, K; Bilton, D; Gadhok, R; Hall, H; Simmonds, NJ | 1 |
| Bourgeois-Nicolaos, N; Cattoir, V; Decousser, JW; Desroches, M; Doucet-Populaire, F; Jehl, F; Lina, G; Potier, J; Vandenesh, F | 1 |
| Hamad, T; Hellmark, B; Nilsdotter-Augustinsson, Å; Söderquist, B | 1 |
| Burns, JL; Emerson, J; Griffith, A; Hoffman, LR; Precit, MR; Wolter, DJ | 1 |
| Fernandes, P | 1 |
| Ahn, JW; Baek, YS; Jeon, J; Song, HJ | 1 |
| Bell, SC; Kidd, TJ; Ramsay, KA; Reid, DW; Sherrard, LJ; Wood, ME; Yerkovich, ST | 1 |
| Aubin, GG; Bémer, P; Corvec, S; Geffroy, L; Guillouzouic, A; Launay, E; Touchais, S | 1 |
| Abouelfetouh, A; El-Nakeeb, M; Kassem, M; Naguib, M | 1 |
| Batty, KT; Clark, B; Davis, TM; Dyer, J; Knippenberg, B; Manning, L; Page-Sharp, M; Salman, S | 1 |
| Cong, Y; Fan, B; Guan, J; Wang, X | 1 |
| Baker, KR; Franzyk, H; Guardabassi, L; Jana, B | 1 |
| Berkowitz, R; Darouiche, R; Fernandes, P; Iglesias-Ussel, MD; Keedy, K; Kreuzer, S; MacLauchlin, C; Mould, DR; Oldach, D; Pushkin, R | 1 |
| Bel, F; Bourguignon, L; Ferry, T; Goutelle, S; Tod, M | 1 |
| Fremlin, GA; Kaur, MR; Orpin, S | 1 |
| Aktas, G; Derbentli, S | 1 |
| Atzori, L; Brundu, MA; Lai, M; Lappi, A; Rongioletti, F | 1 |
| Bogdan, C; Kiefer, A; Melichar, VO | 1 |
| Fernandes, P; Rodriguez-Villalobos, H; Siala, W; Tulkens, PM; Van Bambeke, F | 1 |
| Brennan-Krohn, T; Kirby, JE; Pironti, A | 1 |
| Abutaleb, NS; Dai, M; Kyei-Baffour, K; Mohammad, H; Seleem, MN | 1 |
| Bervar, M; Margaryan, D; Onken, J; Putzier, M; Renz, N; Trampuz, A; Vajkoczy, P; Zahn, R | 1 |
| Alzahrani, KJ; Anafo, RB; Atiase, Y; Dayie, NTKD; Donkor, ES; Duodu, S; Kotey, FCN; Osei, MM; Tetteh-Quarcoo, PB | 1 |
| Hanon, S; Vanderhelst, E; Verbanck, S; Vincken, S | 1 |
| Alsharif, KF; Alzahrani, KJ; Awugah, SA; Bentum, JN; Dayie, NT; Donkor, ES; Duodu, S; Halawani, IF; Kotey, FC; Neizer, ML; Nyarko, MY; Osei, MM; Tetteh-Quarcoo, PB | 1 |
6 review(s) available for fusidic acid and rifampin
| Article | Year |
|---|---|
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells | 2022 |
Advances in antibiotics.
Topics: Adult; Anti-Bacterial Agents; Cephaloridine; Enterobacteriaceae Infections; Fusidic Acid; Gentamicins; Humans; Infant; Infections; Lincomycin; Nalidixic Acid; Penicillin Resistance; Penicillins; Pseudomonas Infections; Respiratory Tract Infections; Rifampin; Sulfamethoxazole; Tuberculosis; Urinary Tract Infections | 1969 |
Antibiotic-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacitracin; Chloramphenicol; Erythromycin; Fusidic Acid; Gentamicins; History, 20th Century; Kanamycin; Lactams; Neomycin; Novobiocin; Penicillin Resistance; Penicillins; Rifampin; Staphylococcus aureus; Tetracycline | 1981 |
Methicillin resistance in Staphylococcus aureus with particular reference to Victorian strains.
Topics: Australia; beta-Lactamases; Cephalosporins; Drug Therapy, Combination; Floxacillin; Fusidic Acid; Humans; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1982 |
Osteomyelitis--a case report.
Topics: Adolescent; Anti-Bacterial Agents; Diagnosis, Differential; Fusidic Acid; Humans; Humerus; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Osteomyelitis; Rifampin; Shoulder Pain; Staphylococcal Infections; Tomography, X-Ray Computed | 2009 |
Fusidic Acid: A Bacterial Elongation Factor Inhibitor for the Oral Treatment of Acute and Chronic Staphylococcal Infections.
Topics: Acute Disease; Administration, Oral; Anti-Bacterial Agents; Chronic Disease; Drug Resistance, Bacterial; Drug Therapy, Combination; Fusidic Acid; Humans; Microbial Sensitivity Tests; Peptide Elongation Factor G; Protein Synthesis Inhibitors; Rifampin; Staphylococcal Infections | 2016 |
2 trial(s) available for fusidic acid and rifampin
| Article | Year |
|---|---|
Successful decolonization of methicillin-resistant Staphylococcus aureus in paediatric patients with cystic fibrosis (CF) using a three-step protocol.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Female; Fusidic Acid; Humans; Infant; Male; Methicillin Resistance; Pneumonia; Rifampin; Severity of Illness Index; Sputum; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin | 2007 |
A Randomized Study Evaluating Oral Fusidic Acid (CEM-102) in Combination With Oral Rifampin Compared With Standard-of-Care Antibiotics for Treatment of Prosthetic Joint Infections: A Newly Identified Drug-Drug Interaction.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Drug Interactions; Drug Therapy, Combination; Female; Fusidic Acid; Humans; Male; Middle Aged; Prosthesis-Related Infections; Rifampin | 2016 |
142 other study(ies) available for fusidic acid and rifampin
| Article | Year |
|---|---|
Caenorhabditis elegans as a model to determine fitness of antibiotic-resistant Salmonella enterica serovar typhimurium.
Topics: Animals; Caenorhabditis elegans; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Mice; Salmonella Infections, Animal; Salmonella typhimurium | 2007 |
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Carrier Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, MDR; Genetic Vectors; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins | 2007 |
Structure-activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; CHO Cells; Cricetinae; Cricetulus; DNA-Directed RNA Polymerases; Furans; Gram-Positive Bacteria; Microbial Sensitivity Tests; Rhodanine; Staphylococcus epidermidis; Structure-Activity Relationship | 2007 |
Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals.
Topics: Aged; Anti-Bacterial Agents; Canada; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Hospitals; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Mupirocin; Staphylococcal Infections; Staphylococcus aureus | 2007 |
Role of the AheABC efflux pump in Aeromonas hydrophila intrinsic multidrug resistance.
Topics: Aeromonas hydrophila; Anti-Bacterial Agents; Bacterial Proteins; Biological Transport, Active; Dipeptides; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA; Substrate Specificity | 2008 |
Delayed development of linezolid resistance in Staphylococcus aureus following exposure to low levels of antimicrobial agents.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Culture Media; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Fusidic Acid; Humans; Linezolid; Microbial Sensitivity Tests; Mutation; Oxazolidinones; Recombination, Genetic; Rifampin; RNA, Ribosomal, 23S; Staphylococcus aureus; Time Factors | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents.
Topics: Animals; Anti-Bacterial Agents; Cricetinae; Fibroblasts; Gram-Negative Bacteria; Kidney Cortex; Lung; Microbial Sensitivity Tests; Microvilli; Polymyxin B; Rats; Structure-Activity Relationship | 2008 |
Use of a surface plasmon resonance method to investigate antibiotic and plasma protein interactions.
Topics: Anti-Bacterial Agents; Blood Proteins; Protein Binding; Surface Plasmon Resonance | 2009 |
Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype a
Topics: Anti-Bacterial Agents; Cell Line; Cystic Fibrosis; Dose-Response Relationship, Drug; Fusidic Acid; Gentamicins; Humans; Macrophages; Microbial Sensitivity Tests; Oxacillin; Phenotype; Protein Binding; Staphylococcus aureus; Thymidine | 2009 |
Continuous clindamycin infusion, an innovative approach to treating bone and joint infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bone Diseases, Infectious; Clindamycin; Cohort Studies; Drug Interactions; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Joint Diseases; Male; Middle Aged; Retrospective Studies; Rifampin; Treatment Outcome; Young Adult | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
Topics: Bacterial Proteins; Drug Resistance, Bacterial; Indoles; Microbial Sensitivity Tests; Mutation; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcus aureus; Structure-Activity Relationship; Substrate Specificity | 2010 |
A novel polymyxin derivative that lacks the fatty acid tail and carries only three positive charges has strong synergism with agents excluded by the intact outer membrane.
Topics: Animals; Anti-Bacterial Agents; Cell Membrane Permeability; Cricetinae; Cricetulus; Drug Synergism; Fibroblasts; Gram-Negative Bacteria; Guinea Pigs; Lung; Male; Microbial Sensitivity Tests; Polymyxin B; Rats; Structure-Activity Relationship | 2010 |
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates.
Topics: Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chlortetracycline; Dipeptides; Doxorubicin; Doxycycline; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Minocycline; Onium Compounds; Organophosphorus Compounds; Tetracycline | 2010 |
Diversity of staphylococcal cassette chromosome mec elements in predominant methicillin-resistant Staphylococcus aureus clones in a small geographic area.
Topics: Chromosomes, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Polymerase Chain Reaction | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Nasal carriage of methicillin-resistant and methicillin-sensitive strains of Staphylococcus sciuri in the Indonesian population.
Topics: Anti-Bacterial Agents; Indonesia; Methicillin; Methicillin Resistance; Phylogeny; Polymerase Chain Reaction; Staphylococcus | 2010 |
LmrS is a multidrug efflux pump of the major facilitator superfamily from Staphylococcus aureus.
Topics: Amino Acid Sequence; Bacterial Proteins; Chloramphenicol; Drug Resistance, Multiple, Bacterial; Ethidium; Membrane Transport Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Onium Compounds; Organophosphorus Compounds; Phylogeny; Sequence Homology, Amino Acid; Sodium Dodecyl Sulfate; Staphylococcus aureus; Trimethoprim; Vancomycin | 2010 |
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Synthesis and antimicrobial activity of chloramphenicol-polyamine conjugates.
Topics: Acetyltransferases; Anti-Bacterial Agents; Bacterial Proteins; Chloramphenicol; Enzyme Assays; Escherichia coli; Gene Expression; Kinetics; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mutation; Phthalic Anhydrides; Spermidine; Succinic Anhydrides | 2015 |
Diaryltriazenes as antibacterial agents against methicillin resistant Staphylococcus aureus (MRSA) and Mycobacterium smegmatis.
Topics: Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium smegmatis; Triazenes | 2017 |
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.
Topics: Anti-Bacterial Agents; Drug Interactions; Molecular Structure | 2017 |
Structure-activity relationship analyses of fusidic acid derivatives highlight crucial role of the C-21 carboxylic acid moiety to its anti-mycobacterial activity.
Topics: Animals; Anti-Bacterial Agents; Cricetulus; Drug Evaluation, Preclinical; Drug Repositioning; Fusidic Acid; Humans; Microbial Sensitivity Tests; Mycobacterium; Structure-Activity Relationship; Tuberculosis | 2020 |
Exploring the structure-activity relationships of diphenylurea as an antibacterial scaffold active against methicillin- and vancomycin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Methicillin; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin; Vancomycin-Resistant Staphylococcus aureus | 2022 |
Developing the Natural Prenylflavone Artocarpin from
Topics: Animals; Anti-Bacterial Agents; Artocarpus; Biofilms; Flavonoids; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus | 2022 |
[Combination of novoimanine with antibiotics with a different mechanism of action].
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Cell Division; Drug Interactions; Drug Synergism; Fusidic Acid; Histones; Kanamycin; Plant Extracts; Plants, Medicinal; Rifampin; Spectinomycin; Staphylococcus aureus | 1975 |
Characterization of the nucleoside triphosphate phosphohydrolase (ATPase) activity of RNA synthesi termination factor p. I. Enzymatic properties and effects of inhibitors.
Topics: Adenosine Triphosphatases; Aurintricarboxylic Acid; Bacterial Proteins; Cations, Divalent; DNA-Directed RNA Polymerases; Edetic Acid; Egtazic Acid; Enzyme Activation; Escherichia coli; Fusidic Acid; Heparin; Kinetics; Magnesium; Phenanthrolines; Rifampin; RNA, Bacterial; Transcription, Genetic | 1977 |
Transcription-translation and translation-messenger RNA decay coupling: separate mechanisms for different messengers.
Topics: Anti-Bacterial Agents; Chloramphenicol; Coliphages; Fusidic Acid; Glucosyltransferases; Phosphotransferases; Protein Biosynthesis; Puromycin; Ribosomes; Rifampin; RNA, Messenger; RNA, Viral; Tetracycline; Transcription, Genetic; Viral Proteins | 1976 |
Marker discrimination in deoxyribonucleic acid-mediated transformation of various Pneumococcus strains.
Topics: Anti-Bacterial Agents; Bacillus subtilis; DNA, Bacterial; Drug Resistance, Microbial; Fusidic Acid; Genes; Genetic Variation; Hybridization, Genetic; Mutation; Phenotype; Rifampin; Streptococcus; Streptococcus pneumoniae; Streptomycin; Sulfanilamides; Transformation, Genetic | 1975 |
Use of electrophoresis in the identification and quantitation of antibiotics administered in combinations.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbenicillin; Clindamycin; Drug Combinations; Electrophoresis; Electrophoresis, Agar Gel; Fusidic Acid; Gentamicins; Lactams; Rifampin | 1977 |
Effect of antibiotics of chemotaxis of human leukocytes.
Topics: Anti-Bacterial Agents; Chemotaxis, Leukocyte; Chloramphenicol; Fusidic Acid; Humans; Neutrophils; Rifampin; Tetracyclines | 1977 |
The absorption of antibiotics in adult patients with coeliac disease.
Topics: Adult; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Celiac Disease; Cephalexin; Clindamycin; Erythromycin; Ethics, Medical; Fusidic Acid; Humans; Intestinal Absorption; Lincomycin; Pivampicillin; Rifampin; Sulfamethoxazole; Trimethoprim | 1975 |
[Recommendations for the indication-justified use of antibiotics. 3: macrolides, lincosamide, glycopeptide antibiotics, fusidic acid, fosfomycin].
Topics: Anti-Bacterial Agents; Fosfomycin; Fusidic Acid; Glycopeptides; Humans; Infections; Lincosamides; Macrolides; Rifampin | 1991 |
The outer membrane permeability-increasing action of linear analogues of polymyxin B nonapeptide.
Topics: Amino Acid Sequence; Cell Membrane; Cell Membrane Permeability; Escherichia coli; Fusidic Acid; Molecular Sequence Data; Oligopeptides; Polymyxin B; Pseudomonas aeruginosa; Rifampin | 1991 |
Pharmacokinetic interaction of antimicrobial agents with levomethadon in drug-addicted AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Female; Fusidic Acid; Humans; Male; Methadone; Opioid-Related Disorders; Opportunistic Infections; Prospective Studies; Rifampin; Stereoisomerism; Substance Abuse, Intravenous; Zidovudine | 1991 |
Do salicylates and ascorbate increase the outer membrane permeability to hydrophobic antibiotics in Pseudomonas aeruginosa?
Topics: Ascorbic Acid; Aspirin; Cell Membrane Permeability; Deoxycholic Acid; Fusidic Acid; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Rifampin; Salicylates; Salicylic Acid | 1990 |
Antibacterial activity of teicoplanin and vancomycin in combination with rifampicin, fusidic acid or fosfomycin against staphylococci on vein catheters.
Topics: Catheters, Indwelling; Drug Interactions; Drug Therapy, Combination; Fosfomycin; Fusidic Acid; Glycopeptides; Humans; Microbial Sensitivity Tests; Rifampin; Staphylococcus epidermidis; Teicoplanin; Vancomycin | 1990 |
Comparative post-antibiotic effect of five antibiotics against ten aerobic gram-positive cocci.
Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Ciprofloxacin; Drug Resistance, Microbial; Fusidic Acid; Gentamicins; Glycopeptides; Gram-Positive Bacteria; Methicillin Resistance; Microbial Sensitivity Tests; Rifampin; Staphylococcus; Staphylococcus aureus; Teicoplanin | 1990 |
Sodium hexametaphosphate sensitizes Pseudomonas aeruginosa, several other species of Pseudomonas, and Escherichia coli to hydrophobic drugs.
Topics: Anti-Bacterial Agents; Chemical Phenomena; Chemistry, Physical; Culture Media; Detergents; Drug Synergism; Escherichia coli; Fluorescence; Fusidic Acid; Microbial Sensitivity Tests; Phosphates; Pseudomonas; Pseudomonas aeruginosa; Rifampin; Sodium Dodecyl Sulfate; Temperature | 1989 |
Conjugative co-transfer of penicillin tolerance and high-level resistance to kanamycin in group A streptococci.
Topics: Conjugation, Genetic; Fusidic Acid; Kanamycin Resistance; Mutation; Penicillin Resistance; Rifampin; Streptococcus pyogenes | 1989 |
In-vitro activity of ciprofloxacin combined with either fusidic acid or rifampicin against Staphylococcus aureus.
Topics: Ciprofloxacin; Drug Interactions; Fusidic Acid; Microbial Sensitivity Tests; Rifampin; Staphylococcus aureus; Time Factors | 1989 |
In-vitro susceptibility of gram-positive cocci to LY146032 teicoplanin, sodium fusidate, vancomycin, and rifampicin.
Topics: Anti-Bacterial Agents; Daptomycin; Fusidic Acid; Glycopeptides; Gram-Positive Bacteria; Microbial Sensitivity Tests; Peptides; Rifampin; Teicoplanin; Vancomycin | 1987 |
Effects of polymyxin B nonapeptide on Aeromonas salmonicida.
Topics: Aeromonas; Animals; Cloxacillin; Complement System Proteins; Erythromycin; Fusidic Acid; In Vitro Techniques; Microbial Sensitivity Tests; Novobiocin; Permeability; Polymyxin B; Polymyxins; Rifampin; Solubility; Trout | 1987 |
Countergradients of nonchemotactic ligands for N-formylmethionylleucylphenylalanine (FMLP) receptors promote FMLP-induced chemotaxis.
Topics: Binding, Competitive; Chemotaxis, Leukocyte; Fusidic Acid; Humans; In Vitro Techniques; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phenylbutazone; Receptors, Formyl Peptide; Receptors, Immunologic; Rifampin; Sulfasalazine; Sulfinpyrazone | 1986 |
Antistaphylococcal activity of teicoplanin in Riyadh, Saudi Arabia.
Topics: Fusidic Acid; Gentamicins; Glycopeptides; Humans; Microbial Sensitivity Tests; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Vancomycin | 1988 |
In vitro activity of six antibiotics against multiresistant staphylococci and other gram-positive cocci.
Topics: Anti-Bacterial Agents; Drug Interactions; Drug Resistance, Microbial; Enterococcus faecalis; Erythromycin; Fusidic Acid; Glycopeptides; Microbial Sensitivity Tests; Mutation; Novobiocin; Rifampin; Staphylococcus; Staphylococcus aureus; Streptococcus; Teicoplanin | 1985 |
The in-vitro activity of some antimicrobial agents against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Fusidic Acid; Gentamicins; Glycopeptides; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Quinolines; Rifampin; Staphylococcus aureus; Staphylococcus Phages; Teicoplanin; Vancomycin | 1985 |
[Comparative results in treating gonorrhea with vibramycin, benemycin and sodium fucidin].
Topics: Adolescent; Adult; Chronic Disease; Doxycycline; Drug Evaluation; Drug Therapy, Combination; Female; Fusidic Acid; Gonorrhea; Humans; Male; Middle Aged; Recurrence; Rifampin; Staphylococcal Toxoid | 1988 |
Staphylococcus epidermidis endocarditis and mitral valve prolapse.
Topics: Adult; Endocarditis, Bacterial; Floxacillin; Fusidic Acid; Heart Valve Prosthesis; Humans; Male; Middle Aged; Mitral Valve; Mitral Valve Prolapse; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1988 |
In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Clindamycin; Fusidic Acid; Imipenem; Methicillin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Penicillin Resistance; Rifampin; Staphylococcus aureus; Thienamycins; Tobramycin; Vancomycin | 1987 |
Antibiotic binding to human polymorphonuclear neutrophils, mouse leukemia L1210 cells and mouse thymocytes.
Topics: Animals; Anti-Bacterial Agents; Clindamycin; Doxycycline; Fusidic Acid; Humans; Leukemia L1210; Mice; Neutrophils; Novobiocin; Phagocytes; Rifampin; T-Lymphocytes; Tetracycline; Thymidine | 1986 |
Bacteriological characters of strains of Staphylococcus aureus submitted to a reference laboratory related to methicillin resistance.
Topics: Bacitracin; Chloramphenicol; Fusidic Acid; Gentamicins; Humans; Methicillin; Minocycline; Neomycin; Novobiocin; Penicillin Resistance; Rifampin; Serotyping; Staphylococcus aureus; Streptomycin; Tetracycline | 1986 |
Interaction between rifampin and fusidic acid against methicillin-resistant coagulase-positive and -negative staphylococci.
Topics: Coagulase; Drug Synergism; Fusidic Acid; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Rifampin; Staphylococcus; Time Factors | 1986 |
Comparison of agar disk diffusion, microdilution broth, and agar dilution for testing antimicrobial susceptibility of coagulase-negative staphylococci.
Topics: Anti-Bacterial Agents; Cephalosporins; Coagulase; Culture Media; Drug Resistance, Microbial; Fusidic Acid; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Rifampin; Sodium Chloride; Staphylococcus; Temperature; Vancomycin | 1987 |
Recognition of streptococcal DNA by a mutant pneumococcus unable to discriminate among markers in pneumococcal DNA.
Topics: DNA, Bacterial; Erythromycin; Fusidic Acid; Lincomycin; Microbial Sensitivity Tests; Mutation; Rifampin; Species Specificity; Streptococcus; Streptococcus pneumoniae; Streptomycin; Transformation, Genetic | 1973 |
Antibiotic inhibitors of the bacterial ribosome.
Topics: Anti-Bacterial Agents; Bacteria; Binding Sites; Chloramphenicol; Dihydrostreptomycin Sulfate; Drug Resistance, Microbial; Erythromycin; Escherichia coli; Fusidic Acid; Lincomycin; Phenotype; Ribosomes; Rifampin; RNA, Messenger; RNA, Transfer; Staphylococcus; Streptomycin; Tetracycline | 1968 |
Polyribosome metabolism in growing and nongrowing Escherichia coli.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacteriolysis; Binding Sites; Chloramphenicol; Depression, Chemical; Escherichia coli; Fusidic Acid; Metabolism; Models, Biological; Models, Structural; Neomycin; Peptides; Ribosomes; Rifampin; RNA, Messenger; RNA, Transfer; Spectinomycin; Streptomycin | 1969 |
[New antibiotics, with the exception of penicillins, streptomycin, tetracyclines and chloramphenicol].
Topics: Anti-Bacterial Agents; Cephalosporins; Chemistry, Pharmaceutical; Erythromycin; Fusidic Acid; Gentamicins; Kanamycin; Leucomycins; Lincomycin; Neomycin; Novobiocin; Oleandomycin; Paromomycin; Polymyxins; Rifampin; Ristocetin; Spectinomycin; Vancomycin; Virginiamycin | 1968 |
Antibiotic sensitivity of staphylococci isolated in Ulanbator. On the occasion of the 50th anniversary of the Mongolian health services.
Topics: Anti-Bacterial Agents; Cephaloridine; Chloramphenicol; Erythromycin; Fusidic Acid; Humans; Kanamycin; Leucomycins; Lincomycin; Microbial Sensitivity Tests; Mongolia; Neomycin; Oxacillin; Penicillin Resistance; Penicillins; Rifampin; Staphylococcal Infections; Staphylococcus; Streptomycin; Tetracycline; Vancomycin | 1972 |
[Methicillin-resistant staphylococci: biological properties and sensitivity to antibiotics].
Topics: Ampicillin; Anti-Bacterial Agents; Carbenicillin; Cephaloridine; Chloramphenicol; Dicloxacillin; Erythromycin; Fusidic Acid; Gentamicins; Kanamycin; Methicillin; Oxacillin; Penicillin G; Penicillin Resistance; Penicillinase; Rifampin; Staphylococcus; Streptomycin; Tetracycline; Vancomycin | 1973 |
Geographical differences in antibiotic sensitivity patterns: comparison of susceptibility of staphylococci in Poland and Germany.
Topics: Cephaloridine; Chloramphenicol; Erythromycin; Framycetin; Fusidic Acid; Geography; Germany, West; Kanamycin; Lincomycin; Nitrofurantoin; Penicillin Resistance; Penicillins; Poland; Rifampin; Species Specificity; Staphylococcus; Streptomycin; Sulfamethoxazole; Tetracycline; Trimethoprim | 1973 |
Gram-positive septicaemia in rheumatoid arthritis.
Topics: Ampicillin; Arthritis, Rheumatoid; Fusidic Acid; Humans; Lincomycin; Male; Middle Aged; Penicillin Resistance; Potassium; Rifampin; Sepsis; Staphylococcal Infections; Urea | 1974 |
Progress towards agreement in reports of antibiotic sensitivity.
Topics: Cephalosporins; Chloramphenicol; Cloxacillin; Erythromycin; Fusidic Acid; Gentamicins; Kanamycin; Lincomycin; Methicillin; Microbial Sensitivity Tests; Neomycin; Novobiocin; Penicillin Resistance; Penicillinase; Penicillins; Rifampin; Staphylococcus; Streptomycin; Sulfonamides; Tetracycline | 1974 |
Metabolism of guanosine tetraphosphate in Escherichia coli.
Topics: Amino Acyl-tRNA Synthetases; Bacterial Proteins; Chloramphenicol; Colicins; Depression, Chemical; Erythromycin; Escherichia coli; Fusidic Acid; Guanine Nucleotides; Hot Temperature; Hydroxylamines; Peptide Chain Initiation, Translational; Puromycin; Rifampin; RNA, Bacterial; Streptomycin; Tetracycline; Trimethoprim; Valine | 1972 |
Intracistronic polarity during dissociation of translation from transcription in Escherichia coli.
Topics: Amino Acids; Carbon Isotopes; Escherichia coli; Fusidic Acid; Galactosidases; Half-Life; Kinetics; Peptide Biosynthesis; Peptide Chain Elongation, Translational; Peptide Chain Termination, Translational; Propionates; Protein Biosynthesis; Rifampin; RNA, Messenger; Starvation; Transcription, Genetic | 1973 |
Dynamic state of the messenger RNA pool specific for extracellular protease in Bacillus amyloliquefaciens: its relevance to the mechanism of enzyme secretion.
Topics: Amino Acids; Antibiotics, Antineoplastic; Bacillus; Biological Transport; Chloramphenicol; Fusidic Acid; Peptide Hydrolases; Protein Biosynthesis; Rifampin; RNA, Messenger; Time Factors; Transcription, Genetic | 1973 |
Permeability control in animal cells by polyenes: a possibility.
Topics: Amphotericin B; Cell Membrane Permeability; Cell Survival; Cells, Cultured; Drug Synergism; Fusidic Acid; L Cells; Nitrosourea Compounds; Rifampin; Vitamin A | 1973 |
The interaction patterns of combined antibacterial agents. Experiments with two agardiffusion methods.
Topics: Ampicillin; Chloramphenicol; Colistin; Drug Antagonism; Drug Synergism; Enterobacteriaceae; Erythromycin; Escherichia coli; Fusidic Acid; Kanamycin; Klebsiella; Methicillin; Nalidixic Acid; Penicillin Resistance; Penicillins; Proteus; Pseudomonas aeruginosa; Rifampin; Salmonella; Staphylococcus; Streptococcus; Streptomycin; Tetracycline | 1966 |
Evidence for an accumulation of messenger RNA specific for extracellular protease and its relevance to the mechanism of enzyme secretion in bacteria.
Topics: Amino Acids; Bacillus; Bacterial Proteins; Carbon Isotopes; Cell Membrane; Chromatography, Affinity; Culture Media; Dactinomycin; Depression, Chemical; Electrophoresis; Enzyme Repression; Fusidic Acid; Genes; Genetic Code; Leucine; Peptide Hydrolases; Ribosomes; Rifampin; RNA, Bacterial; RNA, Messenger; Time Factors | 1972 |
[Combination therapy with antibacterial chemotherapeutic agents in staphylococcal infections].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Endocarditis, Bacterial; Erythromycin; Female; Fusidic Acid; Humans; Infant; Infant, Newborn; Male; Methicillin; Middle Aged; Novobiocin; Penicillin Resistance; Pneumonia, Staphylococcal; Rifampin; Sepsis; Staphylococcal Infections | 1967 |
Antistaphylococcal activity of rifampin with other antibiotics.
Topics: Anti-Bacterial Agents; Cefotaxime; Cefotiam; Clindamycin; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Fusidic Acid; Humans; Methicillin; Microbial Sensitivity Tests; Minocycline; Rifampin; Staphylococcus | 1981 |
Rifampicin-containing antibiotic combinations in the treatment of difficult infections.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Drug Therapy, Combination; Erythromycin; Female; Fusidic Acid; Humans; Infant; Legionnaires' Disease; Male; Meningitis; Middle Aged; Osteomyelitis; Rifampin; Sepsis; Skin Diseases, Infectious; Staphylococcal Infections; Tetracycline; Trimethoprim | 1984 |
In-vitro synergy testing of triple antibiotic combinations against Staphylococcus epidermidis isolates from patients with endocarditis.
Topics: Anti-Bacterial Agents; Dicloxacillin; Drug Combinations; Drug Synergism; Endocarditis, Bacterial; Fusidic Acid; Gentamicins; Humans; Microbial Sensitivity Tests; Rifampin; Staphylococcus epidermidis; Vancomycin | 1984 |
Failure to prevent emergence of bacterial resistance by combination of two antibiotics: fusidic acid and rifampicin.
Topics: Drug Combinations; Drug Resistance, Microbial; Enterococcus faecalis; Fusidic Acid; Microbial Sensitivity Tests; Rifampin | 1980 |
In-vitro effects of vancomycin, rifampicin, and fusidic acid, alone and in combination, against methicillin-resistant Staphylococcus aureus.
Topics: Culture Media; Fusidic Acid; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Rifampin; Staphylococcus aureus; Vancomycin | 1983 |
Antibiotic treatment of Staphylococcus aureus infection in cystic fibrosis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Child, Preschool; Cystic Fibrosis; Dicloxacillin; Female; Fusidic Acid; Humans; Infant; Male; Oxacillin; Probenecid; Pseudomonas Infections; Rifampin; Staphylococcal Infections | 1982 |
In-vitro antibacterial activity of fusidic acid alone and in combination with other antibiotics against methicillin-sensitive and -resistant Staphylococcus aureus.
Topics: Ciprofloxacin; Drug Interactions; Drug Therapy, Combination; Fosfomycin; Fusidic Acid; Gentamicins; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Rifampin; Staphylococcus aureus; Vancomycin | 1994 |
[Diffuse nodular dissemination of thoracic actinomycosis].
Topics: Actinomycosis; Adult; Drug Therapy, Combination; Fusidic Acid; Humans; Male; Metronidazole; Radiography; Rifampin; Tetracycline Resistance; Tetracyclines; Thoracic Diseases; Time Factors | 1994 |
Group of peptides that act synergistically with hydrophobic antibiotics against gram-negative enteric bacteria.
Topics: Anti-Bacterial Agents; Drug Synergism; Enterobacteriaceae; Erythromycin; Fusidic Acid; Gram-Negative Bacteria; Microbial Sensitivity Tests; Micrococcus; Oligopeptides; Pseudomonas aeruginosa; Rifampin | 1996 |
Treatment of endocarditis with teicoplanin: a retrospective analysis of 104 cases.
Topics: Adult; Aged; Anti-Bacterial Agents; Aortic Valve; Endocarditis; Female; Fever; Fusidic Acid; Gentamicins; Humans; London; Male; Microbial Sensitivity Tests; Middle Aged; Prostheses and Implants; Retrospective Studies; Rifampin; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus sanguis; Teicoplanin; Time Factors; Treatment Outcome | 1996 |
Oral treatment of Staphylococcus spp. infected orthopaedic implants with fusidic acid or ofloxacin in combination with rifampicin.
Topics: Administration, Oral; Adult; Aged; Drug Therapy, Combination; Female; Fusidic Acid; Humans; Male; Middle Aged; Ofloxacin; Orthopedic Fixation Devices; Rifampin; Staphylococcal Infections | 1997 |
In vitro susceptibility of penicillin-resistant Streptococcus pneumoniae to levofloxacin, selection of resistant mutants, and time-kill synergy studies of levofloxacin combined with vancomycin, teicoplanin, fusidic acid, and rifampin.
Topics: Anti-Bacterial Agents; Drug Synergism; Drug Therapy, Combination; Fusidic Acid; Levofloxacin; Mutation; Ofloxacin; Penicillin Resistance; Rifampin; Streptococcus pneumoniae; Teicoplanin; Vancomycin | 1996 |
Development of a new CSF-shunt with sustained release of an antimicrobial broad-spectrum combination.
Topics: Bacteria; Bacterial Adhesion; Cerebrospinal Fluid Shunts; Delayed-Action Preparations; Drug Resistance, Microbial; Drug Therapy, Combination; Equipment Contamination; Fusidic Acid; Microbial Sensitivity Tests; Mupirocin; Rifampin; Silicones | 1997 |
Successful management of an infected implantable cardioverter defibrillator with oral antibiotics and without removal of the device.
Topics: Administration, Oral; Anti-Bacterial Agents; Defibrillators, Implantable; Drug Therapy, Combination; Fusidic Acid; Humans; Male; Middle Aged; Rifampin; Staphylococcal Infections; Surgical Wound Infection; Tachycardia, Ventricular; Time Factors | 1997 |
In vitro anti-staphylococcal activity of heparinized biomaterials bonded with combinations of rifampicin.
Topics: Anti-Bacterial Agents; Biocompatible Materials; Cefuroxime; Collagen; Fusidic Acid; Ofloxacin; Rifampin; Staphylococcus epidermidis; Vancomycin | 1998 |
Synergy of antibiotics against Streptomyces somaliensis isolates in vitro.
Topics: Drug Therapy, Combination; Erythromycin; Fusidic Acid; Microbial Sensitivity Tests; Penicillins; Rifampin; Streptomyces; Sulfamethoxazole; Trimethoprim | 1998 |
The independent evolution of resistance to ciprofloxacin, rifampicin, and fusidic acid in methicillin-resistant Staphylococcus aureus in Australian teaching hospitals (1990-1995). Australian Group for Antimicrobial Resistance (AGAR).
Topics: Anti-Bacterial Agents; Australia; Bacteriophage Typing; Ciprofloxacin; Drug Resistance, Multiple; Endemic Diseases; Fusidic Acid; Hospitals, Teaching; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Prevalence; Rifampin; Staphylococcal Infections; Staphylococcus aureus | 1998 |
Comparison of the E test and a proportion dilution method for susceptibility testing of Mycobacterium tuberculosis.
Topics: Amikacin; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Fleroxacin; Fusidic Acid; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1995 |
Investigation of a rifampin, fusidic-acid and mupirocin releasing silicone catheter.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Bacterial Adhesion; Biocompatible Materials; Catheterization; Cerebrospinal Fluid Shunts; Delayed-Action Preparations; Erythrocytes; Fusidic Acid; Hemolysis; Humans; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Mupirocin; Rifampin; Silicones; Staphylococcus aureus; Staphylococcus epidermidis | 1998 |
Killing effects of antibiotics and two-fold antimicrobial combinations on proliferating and non growing staphylococci.
Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Erythromycin; Fusidic Acid; Humans; Microbial Sensitivity Tests; Mupirocin; Prostheses and Implants; Rifampin; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis | 1998 |
Extracellular and intracellular killing in neutrophil granulocytes of Staphylococcus aureus with rifampicin in combination with dicloxacillin or fusidic acid.
Topics: Adult; Dicloxacillin; Drug Therapy, Combination; Fusidic Acid; Humans; Microbial Sensitivity Tests; Neutrophils; Rifampin; Staphylococcus aureus | 1999 |
Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Fusidic Acid; Gene Frequency; Humans; Microbial Sensitivity Tests; Mutation; Rifampin; Staphylococcus aureus | 2001 |
MRSA pyomyositis complicating sickle cell anaemia.
Topics: Adult; Anemia, Sickle Cell; Female; Fusidic Acid; Humans; Leg; Magnetic Resonance Imaging; Methicillin Resistance; Myositis; Rifampin; Staphylococcal Infections; Staphylococcus aureus | 2001 |
Molecular fingerprinting of fusidic acid- and rifampicin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) from Malaysian hospitals.
Topics: Anti-Bacterial Agents; DNA Fingerprinting; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Fusidic Acid; Humans; Malaysia; Methicillin Resistance; Microbial Sensitivity Tests; Rifampin; Staphylococcal Infections; Staphylococcus aureus | 2002 |
In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Ciprofloxacin; Drug Combinations; Fusidic Acid; Gentamicins; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Staphylococcus aureus; Vancomycin | 2003 |
[The impact of antibiotic use on hospital-acquired pneumonia: data of etiology tests].
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bronchoalveolar Lavage Fluid; Ceftazidime; Cefuroxime; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fusidic Acid; Gentamicins; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Penicillins; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Staphylococcus aureus; Sulbactam; Vancomycin Resistance | 2003 |
Rifampicin and sodium fusidate reduces the frequency of methicillin-resistant Staphylococcus aureus (MRSA) isolation in adults with cystic fibrosis and chronic MRSA infection.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Carrier State; Chronic Disease; Cross Infection; Cystic Fibrosis; Female; Fusidic Acid; Humans; Male; Methicillin Resistance; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2004 |
Penetration of fusidic acid and rifampicin into cerebrospinal fluid in low-grade inflammatory meningitis caused by Staphylococcus epidermidis.
Topics: Anti-Bacterial Agents; Cerebrospinal Fluid; Fusidic Acid; Humans; Inflammation; Male; Meningitis, Bacterial; Middle Aged; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis | 2004 |
Hyper-susceptibility of a fusidic acid-resistant mutant of Salmonella to different classes of antibiotics.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Chloramphenicol; Drug Resistance, Bacterial; Fluoroquinolones; Fusidic Acid; Microbial Sensitivity Tests; Mutation; Rifampin; Salmonella typhimurium; Ultraviolet Rays | 2005 |
MRSA eradication in a health care worker with cystic fibrosis; re-emergence or re-infection?
Topics: Adult; Anti-Bacterial Agents; Cystic Fibrosis; Drug Therapy, Combination; Female; Follow-Up Studies; Fusidic Acid; Health Personnel; Humans; Methicillin Resistance; Rifampin; Sputum; Staphylococcal Infections; Staphylococcus aureus | 2005 |
Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections.
Topics: Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Drug Resistance, Bacterial; Drug Therapy, Combination; Fusidic Acid; Methicillin Resistance; Microbial Sensitivity Tests; Prosthesis-Related Infections; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis | 2006 |
An outbreak of methicillin-resistant Staphylococcus aureus skin infections resulting from horse to human transmission in a veterinary hospital.
Topics: Adult; Animals; Animals, Newborn; Community-Acquired Infections; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Female; Fusidic Acid; Horse Diseases; Horses; Hospitals, Animal; Humans; Methicillin Resistance; Mupirocin; Rifampin; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome; Zoonoses | 2006 |
Community-acquired methicillin-resistant Staphylococcus aureus in bone and joint infections: development of rifampicin resistance.
Topics: Administration, Oral; Adolescent; Aged; Anti-Bacterial Agents; Clindamycin; Community-Acquired Infections; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Femur; Fusidic Acid; Hip Prosthesis; Humans; Male; Methicillin Resistance; Osteomyelitis; Prosthesis-Related Infections; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 2006 |
In-vitro activity of quinupristin/dalfopristin, levofloxacin and moxifloxacin against fusidic acid and rifampicin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) from Malaysian hospitals.
Topics: Anti-Bacterial Agents; Aza Compounds; Disease Susceptibility; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Fusidic Acid; Humans; In Vitro Techniques; Levofloxacin; Malaysia; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Rifampin; Staphylococcus aureus; Virginiamycin | 2005 |
Successful treatment of disseminated methicillin-resistant Staphylococcus aureus with fosfomycin, cefoperazone/sulbactam and rifampin followed by fusidic acid and rifampin.
Topics: Anti-Bacterial Agents; Cefoperazone; Drug Therapy, Combination; Fosfomycin; Fusidic Acid; Humans; Male; Methicillin Resistance; Middle Aged; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Sulbactam | 2007 |
Arthroscopic debridement and irrigation of periprosthetic total elbow infection.
Topics: Aged; Arthritis, Infectious; Arthroplasty, Replacement; Arthroscopy; Combined Modality Therapy; Debridement; Drug Therapy, Combination; Elbow Joint; Fusidic Acid; Humans; Isotonic Solutions; Joint Prosthesis; Male; Methicillin; Ossification, Heterotopic; Osteoarthritis; Prosthesis-Related Infections; Rifampin; Ringer's Lactate; Staphylococcal Infections; Staphylococcus aureus; Therapeutic Irrigation | 2006 |
Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis retention and oral rifampicin and fusidic acid.
Topics: Administration, Oral; Aged; Aged, 80 and over; Debridement; Device Removal; Female; Fusidic Acid; Humans; Joint Prosthesis; Male; Middle Aged; Prosthesis-Related Infections; Retrospective Studies; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Treatment Outcome | 2007 |
Effect of antibiotics, alone and in combination, on Panton-Valentine leukocidin production by a Staphylococcus aureus reference strain.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Toxins; Clindamycin; Drug Synergism; Drug Therapy, Combination; Exotoxins; Fusidic Acid; Gene Expression Regulation, Bacterial; Humans; Leukocidins; Linezolid; Microbial Sensitivity Tests; Oxacillin; Oxazolidinones; Reference Standards; Rifampin; Staphylococcus aureus | 2008 |
Large scale variation in Enterococcus faecalis illustrated by the genome analysis of strain OG1RF.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Biofilms; DNA, Bacterial; Drug Resistance, Bacterial; Enterococcus faecalis; Fusidic Acid; Genetic Variation; Genome, Bacterial; Genomics; Interspersed Repetitive Sequences; Membrane Proteins; Mice; Operon; Repetitive Sequences, Nucleic Acid; Rifampin; Sequence Homology, Nucleic Acid | 2008 |
Toxicity of five protein synthesis inhibiting antibiotics and their mixture to limnic bacterial communities.
Topics: Anti-Bacterial Agents; Bacteria; Chloramphenicol; Chlortetracycline; Dose-Response Relationship, Drug; Fusidic Acid; Leucine; Molecular Structure; No-Observed-Adverse-Effect Level; Plankton; Protein Synthesis Inhibitors; Rifampin; Seawater; Streptomycin; Sweden; Water Microbiology; Water Pollutants, Chemical | 2010 |
[Antibiotic resistance dynamics and isolation rate of staphylococci and enterococci from patients of reconstructive surgery units].
Topics: Acetamides; Amoxicillin; Anti-Bacterial Agents; Cefoxitin; Cross Infection; Drug Resistance, Microbial; Enterococcus; Fluoroquinolones; Fusidic Acid; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Moscow; Oxacillin; Oxazolidinones; Rifampin; Surgery, Plastic; Vancomycin | 2011 |
Phase separation behavior of fusidic acid and rifampicin in PLGA microspheres.
Topics: Calorimetry, Differential Scanning; Drug Compounding; Fusidic Acid; Lactic Acid; Microscopy, Confocal; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rifampin; Spectrum Analysis, Raman | 2012 |
Outcome of debridement and retention in prosthetic joint infections by methicillin-resistant staphylococci, with special reference to rifampin and fusidic acid combination therapy.
Topics: Aged; Anti-Bacterial Agents; Arthroplasty; Debridement; Disease-Free Survival; Drug Therapy, Combination; Female; Fusidic Acid; Humans; Joint Prosthesis; Male; Methicillin-Resistant Staphylococcus aureus; Prosthesis-Related Infections; Retrospective Studies; Rifampin; Staphylococcal Infections; Treatment Failure | 2013 |
Fusidic acid and rifampicin co-loaded PLGA nanofibers for the prevention of orthopedic implant associated infections.
Topics: Animals; Anti-Bacterial Agents; Arthroplasty, Replacement; Bacterial Infections; Drug Delivery Systems; Female; Fusidic Acid; Lactic Acid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nanofibers; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prostheses and Implants; Prosthesis-Related Infections; Rats; Rats, Sprague-Dawley; Rifampin; Staphylococcus epidermidis | 2013 |
Mutations in rpoB and fusA cause resistance to rifampicin and fusidic acid in methicillin-resistant Staphylococcus aureus strains from a tertiary hospital in Malaysia.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Fusidic Acid; Malaysia; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Peptide Elongation Factor G; Rifampin; Staphylococcal Infections | 2014 |
Increase in ventilated air spaces after eradication of chronic methicillin-resistant Staphylococcus aureus infection in cystic fibrosis patients.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cystic Fibrosis; Fusidic Acid; Humans; Lung; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Prospective Studies; Respiratory Function Tests; Rifampin; Staphylococcal Infections; Young Adult | 2015 |
Eradication of respiratory tract MRSA at a large adult cystic fibrosis centre.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Body Mass Index; Cystic Fibrosis; Disease Eradication; Drug Therapy, Combination; Female; Fusidic Acid; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Outpatient Clinics, Hospital; Pneumonia, Staphylococcal; Prevalence; Respiratory Tract Infections; Retrospective Studies; Rifampin; Treatment Outcome; United Kingdom | 2015 |
Susceptibility trends including emergence of linezolid resistance among coagulase-negative staphylococci and meticillin-resistant Staphylococcus aureus from invasive infections.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Coagulase; Drug Resistance, Multiple, Bacterial; France; Fusidic Acid; Gentamicins; Hospitals; Humans; Levofloxacin; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Prospective Studies; Rifampin; RNA, Ribosomal, 23S; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Staphylococcal Infections; Staphylococcus epidermidis | 2015 |
Antibiotic susceptibility among Staphylococcus epidermidis isolated from prosthetic joint infections, with focus on doxycycline.
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Clindamycin; Cross Infection; Doxycycline; Drug Resistance, Multiple, Bacterial; Fusidic Acid; Humans; Joint Prosthesis; Linezolid; Microbial Sensitivity Tests; Prosthesis-Related Infections; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis | 2015 |
Optimized In Vitro Antibiotic Susceptibility Testing Method for Small-Colony Variant Staphylococcus aureus.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Cefoxitin; Fluoroquinolones; Fusidic Acid; Humans; Lincosamides; Macrolides; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Trimethoprim, Sulfamethoxazole Drug Combination | 2016 |
Antimicrobial resistance of Staphylococcus aureus isolated from skin infections and its implications in various clinical conditions in Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Clindamycin; Dibekacin; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Fusidic Acid; Gentamicins; Humans; Infant; Infant, Newborn; Ketolides; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Mupirocin; Oxacillin; Republic of Korea; Retrospective Studies; Rifampin; Staphylococcal Skin Infections; Staphylococcus aureus; Teicoplanin; Tetracycline; Vancomycin; Virginiamycin; Young Adult | 2016 |
Methicillin-resistant Staphylococcus aureus acquisition in healthcare workers with cystic fibrosis: a retrospective cross-sectional study.
Topics: Adult; Anti-Bacterial Agents; Australia; Cross Infection; Cross-Sectional Studies; Cystic Fibrosis; Female; Fusidic Acid; Health Personnel; Humans; Incidence; Linezolid; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Multivariate Analysis; Retrospective Studies; Rifampin; Staphylococcal Infections; Treatment Outcome; Young Adult | 2016 |
Failure of combination therapy for Staphylococcus aureus bone infection: a case of in vivo selection with resistance to rifampicin and fusidic acid.
Topics: Adolescent; Anti-Bacterial Agents; Bone Diseases, Infectious; Drug Resistance, Bacterial; Fusidic Acid; Humans; Male; Rifampin; Staphylococcal Infections; Staphylococcus aureus | 2016 |
Investigation and Treatment of Fusidic Acid Resistance Among Methicillin-Resistant Staphylococcal Isolates from Egypt.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Conjugation, Genetic; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Egypt; Fusidic Acid; Gene Expression Regulation, Bacterial; Gentamicins; Humans; Methicillin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Plasmids; Rifampin; Staphylococcal Infections; Sulbactam | 2017 |
Validation and Application of a Dried Blood Spot Assay for Biofilm-Active Antibiotics Commonly Used for Treatment of Prosthetic Implant Infections.
Topics: Adult; Anti-Bacterial Agents; Biofilms; Biological Assay; Chromatography, Liquid; Ciprofloxacin; Dried Blood Spot Testing; Drug Monitoring; Female; Fusidic Acid; Hematocrit; Humans; Male; Middle Aged; Prostheses and Implants; Prosthesis-Related Infections; Reproducibility of Results; Rifampin; Tandem Mass Spectrometry | 2016 |
Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Colistin; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Fosfomycin; Fusidic Acid; Meropenem; Mice; Microbial Sensitivity Tests; Minocycline; Rifampin; Sulbactam; Thienamycins; Tigecycline | 2016 |
A High-Throughput Approach To Identify Compounds That Impair Envelope Integrity in Escherichia coli.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Galactosidase; beta-Lactamases; Biological Transport; Cell Wall; Chromogenic Compounds; Erythromycin; Escherichia coli; Fusidic Acid; Gene Expression; High-Throughput Screening Assays; Hydrolysis; Microbial Sensitivity Tests; Mutation; Nitrophenylgalactosides; Novobiocin; Peptide Library; Peptides; Peptidomimetics; Permeability; Rifampin | 2016 |
Mechanisms of drug-drug interaction between rifampicin and fusidic acid.
Topics: Anti-Bacterial Agents; Drug Interactions; Fusidic Acid; Humans; Microbial Sensitivity Tests; Rifampin; Staphylococcal Infections | 2017 |
Clarithromycin, rifampicin and fusidic acid triple combination therapy for chronic folliculocentric pustulosis of the scalp.
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Folliculitis; Fusidic Acid; Humans; Male; Propionibacterium acnes; Remission Induction; Retrospective Studies; Rifampin; Scalp; Staphylococcus aureus; Treatment Outcome | 2017 |
In vitro activity of daptomycin combinations with rifampicin, gentamicin, fosfomycin and fusidic acid against MRSA strains.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Fusidic Acid; Gentamicins; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rifampin; Staphylococcal Infections | 2017 |
Erosive pustular dermatosis of the scalp and Kindler syndrome: a new association.
Topics: Aged; Anti-Bacterial Agents; Blister; Clobetasol; Drug Therapy, Combination; Epidermolysis Bullosa; Fusidic Acid; Glucocorticoids; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Periodontal Diseases; Photosensitivity Disorders; Rifampin; Scalp Dermatoses; Treatment Outcome | 2018 |
Successful eradication of newly acquired MRSA in six of seven patients with cystic fibrosis applying a short-term local and systemic antibiotic scheme.
Topics: Administration, Inhalation; Administration, Intranasal; Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents, Local; Baths; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Female; Fusidic Acid; Hand Disinfection; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Mupirocin; Retrospective Studies; Rifampin; Staphylococcal Infections; Treatment Outcome; Vancomycin; Young Adult | 2018 |
Activities of Combinations of Antistaphylococcal Antibiotics with Fusidic Acid against Staphylococcal Biofilms in
Topics: Anti-Bacterial Agents; Biofilms; Daptomycin; Fusidic Acid; Humans; Microbial Sensitivity Tests; Moxifloxacin; Rifampin; Staphylococcus epidermidis | 2018 |
Synergistic Activity of Colistin-Containing Combinations against Colistin-Resistant Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Azithromycin; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Enterobacteriaceae; Fusidic Acid; Linezolid; Microbial Sensitivity Tests; Rifampin | 2018 |
An aryl isonitrile compound with an improved physicochemical profile that is effective in two mouse models of multidrug-resistant Staphylococcus aureus infection.
Topics: Animals; Anti-Bacterial Agents; Caco-2 Cells; Disease Models, Animal; Female; Fusidic Acid; Humans; Keratinocytes; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Microsomes, Liver; Nitriles; Rifampin; Skin; Staphylococcal Infections; Staphylococcal Skin Infections | 2019 |
Spinal implant-associated infections: a prospective multicentre cohort study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Biofilms; Child; Cohort Studies; Doxycycline; Female; Fusidic Acid; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Propionibacteriaceae; Prospective Studies; Prosthesis-Related Infections; Quinolones; Rifampin; Spine; Staphylococcus aureus; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2020 |
Methicillin-resistant Staphylococcus aureus (MRSA) nasal carriage among patients with diabetes at the Korle Bu Teaching Hospital.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Carrier State; Clindamycin; Cross-Sectional Studies; Diabetes Complications; Diabetes Mellitus; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Fusidic Acid; Gentamicins; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Nasal Cavity; Norfloxacin; Penicillins; Rifampin; Staphylococcal Infections; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2021 |
Not a wild goose chase: long-lasting MRSA negative status following eradication therapy for chronic MRSA infection in patients with cystic fibrosis.
Topics: Adult; Anti-Bacterial Agents; Child; Clindamycin; Cystic Fibrosis; Fusidic Acid; Humans; Methicillin-Resistant Staphylococcus aureus; Rifampin; Staphylococcal Infections | 2022 |
High prevalence of methicillin-resistant Staphylococcus aureus carriage among infants at the Children's Hospital, Accra, Ghana.
Topics: Anti-Bacterial Agents; Clindamycin; Coagulase; Cross-Sectional Studies; Erythromycin; Fusidic Acid; Gentamicins; Ghana; Hospitals; Humans; Infant; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Prevalence; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |